'Increased evidence that we should be alert': H5N1 bird flu is adapting to mammals in 'new ways'
New research suggests the virus is increasingly adapting to mammalian hosts.
Source: livescience.com
📰 Rxiv June News
Rxiv June News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rxiv June. Real-time updates on events, politics, business and more.
The Pandemic Cause No One Wants to Talk About
Public health officials made SARS-CoV-2 the primary target for pandemic measures. Are there other toxic stressors you need ...
Us Centers For Disease Alma Mater Studiorum University Of Bologna Chemical Toxicology Conditions Linked Disease Control Alma Mater Studiorum University
Source: theepochtimes.com
EUSA Pharma Announces First Patient Enrolled in a Randomised Phase 3 Clinical Trial Investigating Siltuximab in Hospitalised Patients with COVID-19- or Another Respiratory Virus Infection-Associated Acute Respiratory Distress Syndrome (ARDS)
SISCO’) study. 1 The results from 30 patients treated with siltuximab in the ‘SISCO’ study compared with 30 matched controls, showed that treatment with siltuximab led to a 54% reduction in risk of 30-day all-cause mortality. 2 This pivotal study will evaluate the efficacy and safety of standard of care (SOC) with or without intravenous siltuximab in selected hospitalised patients with COVID-19 previously treated with corticosteroids or another respiratory virus infection. Unlike previous...
Source: financialbuzz.com